Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

ARDS Prediction Score in Critically Ill Patients in China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02174081
Recruitment Status : Completed
First Posted : June 25, 2014
Last Update Posted : June 28, 2016
Sponsor:
Information provided by (Responsible Party):
Jianfeng Xie, Southeast University, China

Brief Summary:
ARDS is a severe disease, it's important to predict the incidence of ARDS.

Condition or disease
ARDS Septic Shock

Detailed Description:
From January 1 to January 31, 2012 and from January 1 to January 10, 2013 , all patients admit to the ICUs will be enrolled. The demographic characteristics, diagnosis, formerly medical history, Ventilator indications, Ventilator data, other respiratory treatments, weaning outcome and 28 day mortality will be recorded.

Layout table for study information
Study Type : Observational
Actual Enrollment : 698 participants
Observational Model: Cohort
Official Title: ARDS Prediction Score in Critically Ill Patients in China
Study Start Date : March 2014
Actual Primary Completion Date : March 2016
Actual Study Completion Date : June 2016



Primary Outcome Measures :
  1. incidence of ARDS [ Time Frame: up to 24 months ]
    evaluate the incidence of risk factors of ARDS



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients have the risk of ARDS
Criteria

Inclusion Criteria:

Critically ill patients who admitted into participating ICU

Exclusion Criteria:

Patients with chronic pulmonary disease such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, pulmonary fibrosis and tuberculosis Age less than 18 years old Pregnancy Died within 24 hours from ICU admission ARDS patients who diagnosed 24hours before ICU admission Referral from other hospital to participating ICU Lack of data of ARDS risk factors


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02174081


Locations
Layout table for location information
China, Jiangsu
Zhongda Hospital
Nanjing, Jiangsu, China, 210009
Sponsors and Collaborators
Jianfeng Xie
Investigators
Layout table for investigator information
Principal Investigator: Jianfeng Xie, Dr Southeast University
Layout table for additonal information
Responsible Party: Jianfeng Xie, Zhongda Hospital, Southeast University, China
ClinicalTrials.gov Identifier: NCT02174081    
Other Study ID Numbers: ARDS Prediction system
First Posted: June 25, 2014    Key Record Dates
Last Update Posted: June 28, 2016
Last Verified: June 2016
Keywords provided by Jianfeng Xie, Southeast University, China:
mechanical ventilation, ARDS, Ventilator strategy, outcome
Additional relevant MeSH terms:
Layout table for MeSH terms
Shock, Septic
Critical Illness
Disease Attributes
Pathologic Processes
Sepsis
Infection
Systemic Inflammatory Response Syndrome
Inflammation
Shock